How do I contact Dr Reddy?
For medical information on our products and services, please call us on the numbers below….Medical Information.
| Country | Phone |
|---|---|
| United States | Tel: 1-888-375-3784 (1-888-DRL-DRUG) Timings: Mondays through Friday, 8:00 AM to 10:00 PM, Eastern Time |
Why do you want to join Dr Reddy’s?
Make the world a healthier place. Every day, patients across the world trust us with their health. We have earned this trust through personal integrity, product quality and organizational transparency. We invite you to become a part of a team that does not believe in compromises in the pursuit of short-term success.
Where is Dr Reddys manufactured?
Dr Reddy’s Laboratories launched a new manufacturing facility at its Cuernavaca site in Mexico on 17 March 2010.
Why Dr Reddy is down today?
“This fall in Dr Reddy’s Lab share price is mainly due to the fall in profit in recently ended June 2021 quarter. The market was expecting huge rise in its profit but the company has reported a fall which has come as huge disappointment for the market,” Gorakshkar added.
What does Dr Reddy’s Laboratories do?
Dr. Reddy’s manufactures and markets a wide range of pharmaceuticals in India and overseas. The company has over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology products.
How good is Dr Reddy?
India Ratings and Research Private Limited : India’s Most Respected Credit Rating and Research Agency : India Ratings Affirms Dr. Reddy’s Laboratories’ at ‘IND AA+’; Outlook Stable.
Who is the CEO of Dr Reddy’s Laboratories?
Erez Israeli (Aug 1, 2019–)
Dr. Reddy’s Laboratories/CEO
Who owns Dr Reddys Lab?
Dr. Reddy’s Laboratories
| Type | Public |
|---|---|
| Area served | Worldwide |
| Key people | G. V. Prasad (Co-Chairman & MD) Kallam Satish Reddy (Chairman) Erez Israeli (CEO) |
| Products | Pharmaceuticals, generic drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses, animal health |
| Revenue | ₹17,460 crore (US$2.3 billion) (2020) |